As of 2025-11-17, the Fair Value of Allergy Therapeutics PLC (AGY.L) is -2.87 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.40 GBP, the upside of Allergy Therapeutics PLC is -134.15%.
With the market price of 8.40 GBP and our fair value calculation, Allergy Therapeutics PLC (AGY.L) is not a good investment. Investing in AGY.L stocks now will result in a potential loss of 134.15%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | 7.06 | 2.89 | -13.78 | -43.07 | -40.22 | -17.42 |
| YoY growth | 103.58% | -59.11% | -577.34% | -212.65% | 6.63% | -147.78% |
| Market Cap (mil) | 522.02 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -147.78% |
| TTM earnings | -35.65 |